OTHER CURRENT LIABILITIES (Details) - USD ($)		Sep. 30, 2015	Dec. 31, 2014
Other Liabilities Disclosure [Abstract]
Accrued clinical trial costs		$ 3,528,061	$ 1,706,542
Accrued payroll, bonuses and commission costs		930,913	814,205
Accrued legal and accounting expense		615,946	276,470
Accrued compensated absences		490,170	442,430
Other accrued expenses	[1]	388,268	185,965
Allowance for coupons and returns		208,361	90,446
Allowance for wholesale distributor fees		96,440	160,503
Accrued rent		86,998	91,368
Accrued royalties		41,620	72,710
TOTAL OTHER CURRENT LIABILITIES		$ 6,386,777	$ 3,840,639

[1] In June 2008, we declared and paid a special dividend of $0.40 per share of our Common Stock to all stockholders of record as of June 10, 2008, of which $41,359 remained unclaimed by certain shareholders at March 31, 2015 and December 31, 2014.